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Introduction
Tumor cells grow in nutrient and oxygen deprived microenvironments
and adapt to the suboptimal growth conditions by altering metabolic
pathways. This adaptation process characteristically results in
a tumor phenotype that displays upregulated Hif-1α anaerobic
glycolysis, chronic acidification, reduced rate of overall protein
synthesis, lower rate of cell proliferation and aggressive invasive
characteristics. Most transplantable tumors exhibit a pHe of 6.77.0; the DB-1 melanoma xenografts used here have a pHe=6.7.
Understanding tumor cell reaction to the microenvironment is a
critical factor in predicting the tumor response to radiotherapy. The
glucose regulatory molecule, 6-Phosphofructo-2-Kinase/Fructose-2,6Biphosphatase Isoform-3 (PFKFB3), is a bifunctional enzyme central
to glycolytic flux and downstream of the metabolic stress sensor
AMP-activated protein kinase (AMPK), which we show activates an
isoform of phosphofructokinase (PFK-2).

TIGAR’s ability to reduce lactate production; and downregulation of
mTOR. Conversely, growth at low pH blocked GSH production and
reduced bioreduction.

Conclusion
These results indicate that growth at tumor-like low pH activates
AMPK and PFKFB3 and induces a high glycolytic and apoptotic
potential that is countered by TIGAR and anti-apoptotic proteins,
respectively. Alterations in these pathways lead to predictable
alterations in lactate and oxygen levels, mTOR, GSH and redox state,
and response to radiation. The control of glycolysis can thus alter
acidification, oxygenation and state of bioreduction and modify
tumor cell death pathways. These metabolic pathways that respond
to the microenvironment require incorporation in radiation
treatment strategies.
Supported in part by NIH P01 CA36690 and K22 DE16096.

Methods
All techniques including the growth of the early passage DB-1 human
melanoma and the U87 human glioma cells were standard and have
been published.

Results
As hypothesized, our results demonstrated that growth at chronic
pH 6.7 in air induced AMPK activation resulting in the upregulation
of PFKFB3 and p53 and the downregulation of mammalian TargetOf-Rapamycin (mTOR) in both human tumor cell lines. Conversely,
inhibition of AMPK resulted in downregulation of PFKFB3
and inhibition of glycolysis. When PFKFB3 was transfected and
overexpressed in DB-1 melanoma cells growing at pH 7.3, it induced
a high rate of glycolysis and inhibited oxygen consumption, which
could lead to tumor acidification and oxygenation. By contrast, cells
growing at low pH did not display an increased rate of glycolysis
after PFKFB3 expression because the level of the TP53-induced
Glycolysis and Apoptosis Regulator (TIGAR) was increased.
Cells growing at low pH also were resistant to radiation-induced
apoptosis despite upregulation of p53. This was partially explained
by the expression of the anti-apoptotic proteins, Bcl-2 and Bax;

BODINEJOURNAL

19

